CYP17A1 and prostate carcinoma: For example, inhibition of 17α-hydroxylase-17,20-lyase (P450 17A1 or CYP17A1), an enzyme that is essential for androgen synthesis, is the main mechanism of action of the prostate cancer drug abiraterone23,.24